-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q4 2014 to Q2 2023.
- Eagle Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2023 was $5.4M, a 260% increase year-over-year.
- Eagle Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2023 was $20M, a 423% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $11.4M, a 280% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $3M, a 12.4% increase from 2020.
- Eagle Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2020 was $2.67M, a 5.79% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)